Literature DB >> 1388186

Origin and fate of IgE-bearing lymphocytes. II. Gut-associated lymphoid tissue as sites of first appearance of IgE-bearing B lymphocytes and hapten-specific IgE antibody-forming cells in mice immunized with benzylpenicilloyl-keyhole limpet hemocyanin by various routes: relation to asialo GM1 ganglioside+ cells and IgE/CD23 immune complexes.

D L Auci1, S M Chice, C Heusser, T J Athanassiades, H G Durkin.   

Abstract

The organs in which B cells bearing membrane-bound IgE (sIgE+) and benzylpenicilloyl (BPO)-specific IgE antibody-forming cells (AFC) first appeared were determined in BALB/c mice given BPO-keyhole limpet hemocyanin (10 micrograms) in aluminum hydroxide by various routes (i.p, gavage, s.c., i.v., or i.m.). In mice immunized by the i.p. route, the numbers and location of sIgE+ B cells and asialo GM1 ganglioside (AsGm1+) cells, the location of IgE/CD23 immune complexes, and the numbers of BPO-specific IgE AFC in lymphoid organs were determined. With all routes of immunization, no sIgE+ B cells or BPO-specific IgE AFC were ever detected in any organ before day 8. On day 8, with the s.c., i.v., or i.m. routes, sIgE+ B cells and IgE AFC appeared exclusively in Peyer's patches (PP); with the i.p. or gavage routes, sIgE+ B cells simultaneously appeared in both PP and mesenteric lymph nodes, whereas IgE AFC appeared only in PP. In mice immunized by the i.p. route, IgE/CD23 immune complexes and strikingly increased numbers of AsGm1+ cells transiently appeared only in PP after the appearance and preceding the "disappearance" of the sIgE+ B cells and IgE AFC. The data suggest that specific IgE responses originate in gut-associated lymphoid tissue and appear later in spleen. The data also associate the appearance of IgE/CD23 immune complexes and AsGm1+ cells with the "disappearance" of sIgE+ B cells and IgE AFC from PP.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1388186

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  7 in total

1.  Oral and nasal sensitization promote distinct immune responses and lung reactivity in a mouse model of peanut allergy.

Authors:  Romy Fischer; Jerry R McGhee; Huong Lan Vu; T Prescott Atkinson; Raymond J Jackson; Daniel Tomé; Prosper N Boyaka
Journal:  Am J Pathol       Date:  2005-12       Impact factor: 4.307

2.  Antigen-specific immunoglobulin E+ B cells are preferentially localized within germinal centres.

Authors:  Kathleen A Kelly; Anthony W Butch
Journal:  Immunology       Date:  2006-12-01       Impact factor: 7.397

3.  Oral but not parenteral interleukin (IL)-12 redirects T helper 2 (Th2)-type responses to an oral vaccine without altering mucosal IgA responses.

Authors:  M Marinaro; P N Boyaka; F D Finkelman; H Kiyono; R J Jackson; E Jirillo; J R McGhee
Journal:  J Exp Med       Date:  1997-02-03       Impact factor: 14.307

4.  IgE antibody responses induced by transplantation of the nematode Nippostrongylus brasiliensis in rats: a possible role of nematode excretory-secretory product in IgE production.

Authors:  R Uchikawa; M Yamada; S Matsuda; N Arizono
Journal:  Immunology       Date:  1993-12       Impact factor: 7.397

5.  Microbiome-driven allergic lung inflammation is ameliorated by short-chain fatty acids.

Authors:  A Cait; M R Hughes; F Antignano; J Cait; P A Dimitriu; K R Maas; L A Reynolds; L Hacker; J Mohr; B B Finlay; C Zaph; K M McNagny; W W Mohn
Journal:  Mucosal Immunol       Date:  2017-10-25       Impact factor: 7.313

6.  IgE antibody production is associated with suppressed interferon-gamma levels in mesenteric lymph nodes of rats infected with the nematode Nippostrongylus brasiliensis.

Authors:  R Uchikawa; M Yamada; S Matsuda; A Kuroda; N Arizono
Journal:  Immunology       Date:  1994-07       Impact factor: 7.397

7.  Reduced severity of peanut-induced anaphylaxis in TLR9-deficient mice is associated with selective defects in humoral immunity.

Authors:  M C Berin; W Wang
Journal:  Mucosal Immunol       Date:  2012-06-20       Impact factor: 7.313

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.